CARDIZEM Safety Questions, CARDIZEM Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about CARDIZEM. Our extensive database of CARDIZEM adverse events and CARDIZEM warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about CARDIZEM

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




CARDIZEM Safety Reports

Total CARDIZEM reports: 63.
CARDIZEM FDA safety alerts: 2005 .
Reported deaths: 5    Reported hospitalizations: 27.
Take CARDIZEM Side Effects Survey or Share Your CARDIZEM Story. CARDIZEM Usage.

Health Professional from UNITED STATES reported CARDIZEM problem on Jan 16, 2007. Male patient, 74 years of age, weighting 171.0 lb, was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered, refusal of treatment by patient, sinus bradycardia. CARDIZEM dosage: unknown. Patient was hospitalized. Patient recovered.

CARDIZEM problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 05, 2007. Female patient was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, hyponatraemia. CARDIZEM dosage: 120 MG Q DAY PO. During the same period patient was treated with CARDIZEM CD, DIOVAN HCT, DIOVAN HCT. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CARDIZEM problem on Jan 08, 2007. Female patient, 58 years of age, weighting 150.0 lb, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: arrhythmia, asthma, blood pressure fluctuation, gastrooesophageal reflux disease, heart rate increased, hypercholesterolaemia, hypersensitivity, thrombosis. CARDIZEM dosage: 120 MG Q DAY PO. During the same period patient was treated with LOVENOX, AVAPRO, ASPIRIN, ZYRTEC, SINGULAIR, NEXIUM, COLACE, UNITHROID. Patient was hospitalized. Patient recovered.

CARDIZEM problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 27, 2006. Male patient, 76 years of age, weighting 220.0 lb, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: heart rate decreased, loss of consciousness. CARDIZEM dosage: unknown. During the same period patient was treated with ATENOLOL, HYDROCHLOROTHIAZIDE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from CANADA reported CARDIZEM problem on Jan 23, 2007. Female patient, 58 years of age, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: back disorder, rash. CARDIZEM dosage: 240 MG Q DAY PO. During the same period patient was treated with LISINOPRIL. Patient recovered.

CARDIZEM problem was reported by a Consumer or non-health professional from BRAZIL on Feb 07, 2007. Male patient, 84 years of age, was diagnosed with blood pressure increased, erectile dysfunction and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, chest pain, dizziness, malaise. CARDIZEM dosage: unknown. During the same period patient was treated with VIAGRA, CIALIS, SUSTRATE. Patient recovered.

Consumer or non-health professional from NORWAY reported CARDIZEM problem on Sept 11, 2006. Female patient, 63 years of age, was diagnosed with arrhythmia, hypercholesterolaemia and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: balance disorder, convulsion, dry mouth, fatigue, muscle twitching, nausea, tinnitus. CARDIZEM dosage: 180 MG BID PO. During the same period patient was treated with SIMVASTATIN, TRIATEC, LOSEC, LYRICA, SYMBICORT, AIROMIR. Patient recovered.

CARDIZEM problem was reported by a Health Professional from UNITED STATES on July 07, 2006. Female patient, 74 years of age, was diagnosed with post herpetic neuralgia and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: anaemia, atrioventricular block second degree, azotaemia, blood chloride decreased, blood creatinine increased, blood glucose increased, bradycardia, bundle branch block right, carbon dioxide decreased. CARDIZEM dosage: 180 MG QD. During the same period patient was treated with LYRICA, EZETIMIBE, LISINOPRIL, PROCARDIA, ZESTORETIC, KETAMINE, GABAPENTIN, BACLOFEN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported CARDIZEM problem on Oct 26, 2006. Male patient, 80 years of age, was diagnosed with hypertension, atrial fibrillation and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: abdominal distension, bradycardia, cardio-respiratory arrest, chronic obstructive pulmonary disease, condition aggravated, cough, diabetic gastroparesis, erosive oesophagitis, gallbladder enlargement. CARDIZEM dosage: unknown. During the same period patient was treated with NORVASC, DIOVAN, POTASSIUM ACETATE, GLUCOPHAGE. Patient was hospitalized. Patient died on 09/28/2006.

CARDIZEM problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2007. Male patient, weighting 190.0 lb, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: headache, hypertension, incorrect dose administered. CARDIZEM dosage: 300 MG DAILY PO. Patient recovered.

Physician from UNITED STATES reported CARDIZEM problem on Feb 26, 2007. Male patient, 80 years of age, was diagnosed with hypertension, atrial fibrillation and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: bradycardia, cardio-respiratory arrest, chronic obstructive pulmonary disease, condition aggravated, diabetic gastroparesis, erosive oesophagitis, gallbladder disorder, hyperkalaemia, hypotension. CARDIZEM dosage: unknown. During the same period patient was treated with NORVASC, DIOVAN, POTASSIUM ACETATE, GLUCOPHAGE. Patient was hospitalized. Patient died on 09/28/2006.

CARDIZEM problem was reported by a Health Professional from UNITED STATES on Mar 06, 2007. Male patient was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, diarrhoea, gastroenteritis viral, nausea, vomiting. CARDIZEM dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CARDIZEM problem on Mar 08, 2007. Female patient, 65 years of age, weighting 92.00 lb, was diagnosed with raynaud's phenomenon and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, amnesia, fatigue, feeling abnormal, nervousness, pollakiuria, transient ischaemic attack. CARDIZEM dosage: 360 MG Q DAY PO. During the same period patient was treated with CARDIZEM LA, TOPROL, MORPHINE, NEXIUM, ACIPHEX, LIPITOR, PREMIQUE. Patient recovered.

CARDIZEM problem was reported by a Consumer or non-health professional from BRAZIL on Mar 28, 2007. Female patient, 63 years of age, weighting 176.4 lb, was diagnosed with hypertension, diabetes mellitus and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia, varicose vein operation. CARDIZEM dosage: 90 MG, BID. During the same period patient was treated with METFORMIN, FUROSEMIDE, AMILORIDE HYDROCHLORIDE, FLUOXETINE, OROXADIN, COZAAR, PARIET, CONDROFLEX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CARDIZEM problem on Mar 22, 2007. Male patient, 65 years of age, was diagnosed with heart rate increased, erectile dysfunction, bronchitis and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, bronchitis, dehydration, ejaculation failure, flushing, heart rate decreased, heart rate irregular, no therapeutic response. CARDIZEM dosage: 120 MG Q DAY PO. During the same period patient was treated with CARDIZEM CD, VIAGRA, ZITHROMAX, RITALIN, CAFFEINE, LEVOTHYROXINE, CLONAZEPAM, COZAAR. Patient was hospitalized. Patient recovered.

CARDIZEM problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 03, 2007. Male patient, 62 years of age, weighting 189.6 lb, was diagnosed with tremor, blood testosterone decreased and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: abasia, balance disorder, brain damage, cardiac arrest, heart rate decreased, memory impairment. CARDIZEM dosage: 120 MG Q DAY PO. During the same period patient was treated with ANDROGEL, PERCOCET, ZOLOFT, DEPAKOTE, WELLBUTRIN. Patient was hospitalized and became disabled. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CARDIZEM problem on Apr 19, 2007. Female patient, 66 years of age, was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: asthenia, dyspnoea, fall, loss of consciousness, palpitations, walking aid user. CARDIZEM dosage: unknown. During the same period patient was treated with KLONOPIN, TRAZODONE, DYAZIDE, ACTONEL, ZELNORM. Patient recovered.

CARDIZEM problem was reported by a Pharmacist from UNITED STATES on May 05, 2006. Female patient, 87 years of age, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: visual disturbance. CARDIZEM dosage: 180 MG Q DAY PO. During the same period patient was treated with COUMADIN, ULTRACET. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CARDIZEM problem on June 19, 2006. Female patient, 58 years of age, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: dyspnoea, oedema peripheral, pain in extremity, pharyngeal oedema, swollen tongue. CARDIZEM dosage: 240 MG QAM PO. During the same period patient was treated with ZYRTEC. Patient recovered.

CARDIZEM problem was reported by a Physician from UNITED STATES on Mar 06, 2006. Female patient was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: angioedema, hypersensitivity. CARDIZEM dosage: 180 MG Q DAY PO. Patient recovered.

Health Professional from UNITED STATES reported CARDIZEM problem on Feb 10, 2006. Female patient, 88 years of age, weighting 107.0 lb, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: exfoliative rash, hypersensitivity, oedema peripheral. CARDIZEM dosage: 360 MG Q DAY. During the same period patient was treated with LOTREL, HYDROCHLOROTHIAZIDE, CALCIUM SUPPLEMENT PLUS VITAMIN D, ADVAIR DISKUS, ALBUTEROL, SYNTHROID, LOPRESSOR, VITAMIN CAP. Patient recovered.

CARDIZEM problem was reported by a Consumer or non-health professional from UNITED STATES on May 07, 2007. Female patient, 39 years of age, weighting 227.0 lb, was diagnosed with supraventricular tachycardia and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: abdominal distension, chest pain, dyspnoea, gastrointestinal disorder, musculoskeletal pain. CARDIZEM dosage: 1 PILL -120 MG- 1 PER DAY PO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CARDIZEM problem on May 15, 2007. Female patient was diagnosed with hypertension, stent placement and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: chills, cough, pain, pulmonary embolism, pyrexia. CARDIZEM dosage: unknown. During the same period patient was treated with DIOVAN, PLAVIX. Patient was hospitalized. Patient recovered.

CARDIZEM problem was reported by a Consumer or non-health professional from UNITED STATES on May 16, 2007. Female patient, 66 years of age, weighting 170.0 lb, was diagnosed with oesophageal disorder, osteoporosis, irritable bowel syndrome and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: asthenia, dyspnoea, fall, joint injury, loss of consciousness, palpitations, walking aid user. CARDIZEM dosage: unknown. During the same period patient was treated with KLONOPIN, TRAZODONE, DYAZIDE, ACTONEL, ZELNORM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CARDIZEM problem on May 07, 2007. Male patient, 71 years of age, was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, flushing, hyperhidrosis, myocardial infarction. CARDIZEM dosage: unknown. During the same period patient was treated with COUMADIN, ASPIRIN. Patient recovered.

CARDIZEM problem was reported by a Consumer or non-health professional from UNITED STATES on May 31, 2007. Female patient, 88 years of age, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: atrioventricular block complete, cardiac disorder, chest pain. CARDIZEM dosage: unknown. During the same period patient was treated with METOPROLOL SUCCINATE, DYAZIDE, PLAVIX, PROTONIX, CARDIZEM CD, CELEBREX, ARICEPT, NORVASC. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported CARDIZEM problem on May 22, 2007. Male patient was diagnosed with heart rate increased, erectile dysfunction, bronchitis and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood caffeine increased, bronchitis, dehydration, dizziness, ejaculation failure, flushing, heart rate decreased. CARDIZEM dosage: (120 MG QD ORAL), ORAL. During the same period patient was treated with VIAGRA, ZITHROMAX, RITALIN, CAFFEINE, VITAMIN WITH MINERALS, ASPIRIN, METOPROLOL SUCCINATE, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

CARDIZEM problem was reported by a Consumer or non-health professional from UNITED STATES on May 25, 2007. Male patient, 71 years of age, was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: flushing, hyperhidrosis. CARDIZEM dosage: 120 MG QD ORAL. During the same period patient was treated with COUMADIN, ASPIRIN, VITAMIN. Patient recovered.

Physician from UNITED STATES reported CARDIZEM problem on June 08, 2007. Female patient, 66 years of age, weighting 170.0 lb, was diagnosed with oesophageal disorder, osteoporosis, irritable bowel syndrome and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: dyspnoea, fall, joint injury, loss of consciousness, muscular weakness, palpitations, walking aid user. CARDIZEM dosage: unknown. During the same period patient was treated with KLONOPIN, TRAZODONE, DYAZIDE, ACTONEL, ZELNORM. Patient recovered.

CARDIZEM problem was reported by a Consumer or non-health professional from UNITED STATES on June 27, 2007. Female patient, 62 years of age, weighting 140.0 lb, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: blood pressure increased. CARDIZEM dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported CARDIZEM problem on July 20, 2006. Male patient, 65 years of age, weighting 148.0 lb, was diagnosed with arrhythmia supraventricular, atrial fibrillation and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: anxiety, blood pressure fluctuation, chills, heart rate decreased, heart rate increased, incorrect dose administered, nervousness, pyrexia. CARDIZEM dosage: 60 MG QID PO. During the same period patient was treated with DILTIAZEM, SIMVASTATIN, OMEPRAZOLE, GABAPENTIN, OLANZAPINE, SERTRALINE, BACLOFEN. Patient was hospitalized. Patient recovered.

CARDIZEM problem was reported by a Pharmacist from UNITED STATES on July 20, 2006. Male patient, 76 years of age, weighting 219.0 lb, was diagnosed with blood pressure, dementia alzheimer's type and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: asthenia, bradycardia, dizziness, syncope. CARDIZEM dosage: unknown. During the same period patient was treated with ARICEPT. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported CARDIZEM problem on July 05, 2006. Female patient, 59 years of age, weighting 169.0 lb, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: arrhythmia. CARDIZEM dosage: unknown. During the same period patient was treated with CARDIZEM LA, SYNTHROID, SPIRONOLACTONE W, BIVACTIN VITAMIN WITH CALCIUM, OCUVITE LUTEIN. Patient died on 04/16/2006.

CARDIZEM problem was reported by a Consumer or non-health professional from UNITED STATES on June 09, 2006. Male patient, 74 years of age, was diagnosed with blood cholesterol and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: aneurysm, arthritis, blood alkaline phosphatase increased, blood potassium decreased, hepatic enzyme increased, joint effusion, knee arthroplasty, oedema peripheral, post procedural complication. CARDIZEM dosage: unknown. During the same period patient was treated with LIPITOR, FLOMAX, NEXIUM, HYZAAR, PROSCAR. Patient recovered.

Physician from UNITED STATES reported CARDIZEM problem on Aug 02, 2006. Male patient, 80 years of age, weighting 151.0 lb, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: nausea. CARDIZEM dosage: unknown. Patient recovered.

CARDIZEM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 11, 2006. Female patient, 50 years of age, weighting 135.0 lb, was diagnosed with hypertension, tachycardia and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: erythema, flushing, pruritus, rash, urticaria. CARDIZEM dosage: TABLET-240 MG 1 TIME PER DAY PO. During the same period patient was treated with CARDIZEM LA. Patient recovered.

Pharmacist from UNITED STATES reported CARDIZEM problem on Aug 03, 2006. Male patient, 74 years of age, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: bradycardia. CARDIZEM dosage: 120 MG QD PO. During the same period patient was treated with PREDNISONE, SPIRIVA, AUGMENTIN, METOPROLOL TARTRATE, FLOMAX, FLOVENT, AVANDIA, INSULIN. Patient recovered.

CARDIZEM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 11, 2006. Female patient, 54 years of age, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: arthralgia, gait disturbance, gout, impaired work ability, pain in extremity, pollakiuria. CARDIZEM dosage: 240 MG Q DAY. During the same period patient was treated with TRIAMTERENE AND HYDROCHLOROTHIAZIDE. Patient recovered.

Physician from UNITED STATES reported CARDIZEM problem on June 15, 2006. Female patient, 68 years of age, weighting 125.7 lb, was diagnosed with osteoporosis and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: arthralgia, dermatitis, exfoliative rash, serum sickness, swelling. CARDIZEM dosage: unknown. During the same period patient was treated with FOSAMAX, ISOSORBIDE MONONITRATE, LISINOPRIL, LOVASTATIN, ZETIA. Patient recovered.

CARDIZEM problem was reported by a Health Professional from UNITED STATES on Sept 01, 2006. Female patient was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: device failure. CARDIZEM dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CARDIZEM problem on Aug 18, 2006. Female patient, 69 years of age, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: aortic aneurysm, intracranial aneurysm, malaise, parathyroid disorder. CARDIZEM dosage: 180 MG. During the same period patient was treated with LASIX, AVAPRO, CALCIUM GLUCONATE. Patient was hospitalized. Patient recovered.

CARDIZEM problem was reported by a Physician from UNITED STATES on June 15, 2006. Female patient, 68 years of age, weighting 125.7 lb, was diagnosed with osteoporosis and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: dermatitis, exfoliative rash, serum sickness. CARDIZEM dosage: unknown. During the same period patient was treated with FOSAMAX, ISOSORBIDE MONONITRATE, LISINOPRIL, LOVASTATIN, ZETIA. Patient recovered.

Pharmacist from UNITED STATES reported CARDIZEM problem on Sept 21, 2006. Male patient, 59 years of age, weighting 207.9 lb, was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: oedema. CARDIZEM dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZDE. Patient was hospitalized. Patient recovered.

CARDIZEM problem was reported by a Health Professional from UNITED STATES on Sept 11, 2006. Female patient, 73 years of age, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled, coronary artery stenosis, fatigue, flushing, myalgia, nausea, overdose, tremor. CARDIZEM dosage: 180 MG Q DAY. During the same period patient was treated with PRAVACHOL, COZAAR, THYROID, PLAVIX, DILTIAZEM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CARDIZEM problem on Sept 26, 2006. Female patient, 74 years of age, weighting 138.0 lb, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: anxiety, blood pressure inadequately controlled, blood pressure increased. CARDIZEM dosage: 240 MG QAM PO. During the same period patient was treated with CARDIZEM CD, LIPITOR, ASPIRIN. Patient recovered.

CARDIZEM problem was reported by a Pharmacist from UNITED STATES on Oct 30, 2006. Male patient, 79 years of age, was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: bradycardia, cardio-respiratory arrest, hypotension, resuscitation, tachycardia. CARDIZEM dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CARDIZEM problem on Oct 13, 2006. Female patient was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, myocardial infarction. CARDIZEM dosage: 180 MG Q DAY. During the same period patient was treated with LABETALOL, DYAZIDE. Patient recovered.

CARDIZEM problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 13, 2006. Female patient, 75 years of age, was diagnosed with tachycardia and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, angina pectoris, dyspnoea, fatigue, feeling abnormal, headache, nasal congestion. CARDIZEM dosage: 30 MG TID PO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CARDIZEM problem on Oct 16, 2006. Female patient, 54 years of age, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: arthralgia, decreased activity, gait disturbance, gouty arthritis, myalgia, pain in extremity, pollakiuria. CARDIZEM dosage: 240 MG Q DAY. During the same period patient was treated with TRIAMTERENE AND HYDROCHLOROTHIAZIDE. Patient recovered.

CARDIZEM problem was reported by a Pharmacist from UNITED STATES on Nov 16, 2006. Female patient, 30 years of age, was diagnosed with atrial fibrillation, hypertension, cellulitis and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: blister. CARDIZEM dosage: unknown. During the same period patient was treated with TEQUIN, FOSAMAX, ASPIRIN, BACITRACIN OIMENT, NEURONTIN, IBUPROFEN, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CARDIZEM problem on Nov 13, 2006. Female patient, 49 years of age, weighting 172.0 lb, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, dyspnoea, feeling abnormal, heart rate increased, nausea. CARDIZEM dosage: 120 MG QAM PO. During the same period patient was treated with DILTIAZEM, CARDIZEM LA. Patient was hospitalized. Patient recovered.

CARDIZEM problem was reported by a Health Professional from UNITED STATES on Nov 17, 2006. Female patient, 83 years of age, weighting 197.0 lb, was diagnosed with atrial fibrillation, anaemia and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, atrial fibrillation, cardiac arrest, condition aggravated, disease recurrence, haemodialysis, hypoxic encephalopathy, renal failure acute. CARDIZEM dosage: unknown. During the same period patient was treated with DIGOXIN, PROCRIT, LASIX, ALBUMIN, LATANOPROST, PROTONIX, MORPHINE. Patient was hospitalized and became disabled. Patient died on 09/10/2005.

Consumer or non-health professional from UNITED STATES reported CARDIZEM problem on Nov 27, 2006. Female patient, 80 years of age, weighting 100.0 lb, was diagnosed with angina pectoris, hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: bladder disorder, bladder spasm, burning sensation, cerebrovascular accident, dysuria, erythema, glaucoma, muscle spasms, nocturia. CARDIZEM dosage: 240 MG QD PO. During the same period patient was treated with CARDIZEM CD, SYNTHROID, NITROGLYCERIN, ASPIRIN, ZALATAN, ALPHAGAN. Patient was hospitalized. Patient recovered.

CARDIZEM problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 05, 2006. Female patient, 62 years of age, was diagnosed with atrial fibrillation and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: angina pectoris, atrial fibrillation, condition aggravated, dizziness, economic problem, headache, oedema peripheral, pain in jaw. CARDIZEM dosage: 120 MG Q DAY PO. During the same period patient was treated with CARDIZEM CD, CARDIZEM LA, CARDIZEM LA, CARDIZEM LA, PLAVIX, DIGOXIN, TOPROL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CARDIZEM problem on Dec 12, 2006. Male patient, 74 years of age, weighting 215.0 lb, was diagnosed with blood pressure increased and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: blood pressure diastolic decreased, blood pressure increased, dizziness, heart rate irregular, incorrect dose administered, metabolic disorder. CARDIZEM dosage: 420 MG QAM PO. During the same period patient was treated with CARDIZEM LA, CARDIZEM LA, CARDIZEM LA, CARDIZEM LA, LIPITOR, DIOVAN, ALTACE, PLAVIX. Patient recovered.

CARDIZEM problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 21, 2006. Male patient, 41 years of age, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: arthralgia, clubbing, dysstasia, feeling abnormal, influenza, influenza like illness, joint swelling, nasopharyngitis. CARDIZEM dosage: 180 MG QD PO. During the same period patient was treated with CIPRO, CORGARD, PROCARDIA. Patient recovered.

Pharmacist from UNITED STATES reported CARDIZEM problem on July 20, 2007. Female patient, 82 years of age, weighting 145.0 lb, was diagnosed with blood pressure, hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: poor quality sleep. CARDIZEM dosage: 60MG Q6H PO. During the same period patient was treated with ASPIRIN. Patient recovered.

CARDIZEM problem was reported by a Physician from UNITED STATES on July 20, 2007. Male patient, weighting 184.0 lb, was diagnosed with myocardial infarction and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, flushing, hyperhidrosis, hypotension. CARDIZEM dosage: (180 MG QD ORAL). During the same period patient was treated with CARDIZEM CD, COUMADIN, ASPIRIN, VITAMIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CARDIZEM problem on July 27, 2007. Female patient, 71 years of age, was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: angina pectoris, cardiac disorder, heart rate increased, nausea, swelling. CARDIZEM dosage: unknown. Patient was hospitalized. Patient recovered.

CARDIZEM problem was reported by a Pharmacist from UNITED STATES on Aug 15, 2007. Female patient was diagnosed with atrial fibrillation and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: no therapeutic response. CARDIZEM dosage: 240MG, 180MG, 120MG BID PO. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported CARDIZEM problem on Aug 15, 2007. Female patient, weighting 154.0 lb, was diagnosed with hypertension and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: bradycardia, dizziness, hyperhidrosis, hypotension, presyncope. CARDIZEM dosage: unknown. During the same period patient was treated with ALTACE, COUMADIN. Patient was hospitalized. Patient recovered.

CARDIZEM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2007. Female patient, weighting 181.0 lb, was diagnosed with angina pectoris, coronary artery disease, heart rate increased and was treated with CARDIZEM. After drug was administered, patient experienced the following problems/side effects: angina pectoris, diabetes mellitus, dyspnoea, heart rate increased, nausea, oedema peripheral, palpitations, swelling face. CARDIZEM dosage: (120 MG QD ORAL). Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CARDIZEM problem on Sept 13, 2007. Female patient, weighting 114.0 lb, was treated with CARDIZEM. CARDIZEM dosage: 240 MG DF. Patient died on 07/16/2007.

Ask Our Patient Community about CARDIZEM

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert